132 related articles for article (PubMed ID: 9526961)
1. Urokinase localization and activity in isolated eosinophils.
Mabilat-Pragnon C; Janin A; Michel L; Thomaïdis A; Legrand Y; Soria C; Lu H
Thromb Res; 1997 Nov; 88(4):373-9. PubMed ID: 9526961
[TBL] [Abstract][Full Text] [Related]
2. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
3. Subcellular distribution of urokinase and urokinase receptor in human neutrophils determined by immunoelectron microscopy.
Pedersen TL; Plesner T; Horn T; Høyer-Hansen G; Sørensen S; Hansen NE
Ultrastruct Pathol; 2000; 24(3):175-82. PubMed ID: 10914429
[TBL] [Abstract][Full Text] [Related]
4. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils.
Guilbert M; Ferland C; Bossé M; Flamand N; Lavigne S; Laviolette M
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):97-104. PubMed ID: 10385597
[TBL] [Abstract][Full Text] [Related]
5. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
6. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
7. Increased migration of murine keratinocytes under hypoxia is mediated by induction of urokinase plasminogen activator.
Daniel RJ; Groves RW
J Invest Dermatol; 2002 Dec; 119(6):1304-9. PubMed ID: 12485432
[TBL] [Abstract][Full Text] [Related]
8. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
[TBL] [Abstract][Full Text] [Related]
9. Type 4A cAMP-specific phosphodiesterase is stored in granules of human neutrophils and eosinophils.
Pryzwansky KB; Madden VJ
Cell Tissue Res; 2003 Jun; 312(3):301-11. PubMed ID: 12764607
[TBL] [Abstract][Full Text] [Related]
10. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
Reinartz J; Link J; Todd RF; Kramer MD
Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
[TBL] [Abstract][Full Text] [Related]
11. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
[TBL] [Abstract][Full Text] [Related]
12. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system.
Ferland C; Guilbert M; Davoine F; Flamand N; Chakir J; Laviolette M
J Leukoc Biol; 2001 May; 69(5):772-8. PubMed ID: 11358986
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
14. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
15. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
Albo D; Rothman VL; Roberts DD; Tuszynski GP
Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system.
Michaud-Levesque J; Rolland Y; Demeule M; Bertrand Y; Béliveau R
Biochim Biophys Acta; 2005 Apr; 1743(3):243-53. PubMed ID: 15843038
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts.
Weckroth M; Vaheri A; Myöhänen H; Tukiainen E; Sirén V
Wound Repair Regen; 2001; 9(4):314-22. PubMed ID: 11679140
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
19. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
